Stefanie de Groot

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Stefanie de Groot, Rieneke T. Lugtenberg, Danielle Cohen et al. · Nature Communications · 2020 · 335 citations · Full text

Medicine, Nutritional Sciences, Oncology +17

The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

Stefanie de Groot, Maaike P.G. Vreeswijk, Marij J.P. Welters et al. · BMC Cancer · 2015 · 257 citations · Full text

Medicine, Oncology, Pharmacology +16

Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013–14) trial

Rieneke T. Lugtenberg, Stefanie de Groot, Maarten J. Fischer et al. · Breast Cancer Research and Treatment · 2020 · 62 citations · Full text

Medicine, Nutrition, Oncology +17

Tumor‐stroma ratio is associated with <scp>Miller‐Payne</scp> score and pathological response to neoadjuvant chemotherapy in <scp>HER2</scp>‐negative early breast cancer

Sophie C. Hagenaars, Stefanie de Groot, Daniëlle Cohen et al. · International Journal of Cancer · 2021 · 43 citations · Full text

Medicine, Oncology, Breast Oncology +14

Insulin-like growth factor 1 receptor expression and IGF1R 3129G &gt; T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Stefanie de Groot, Ayoub Charehbili, Hanneke W.M. van Laarhoven et al. · Breast Cancer Research · 2016 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +16